Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...

Similarly, Stryker's investments in ... Pricing Trends Over the next decade, the cost of knee replacement surgeries is expected to increase, particularly in markets where robotic assistance and ...

The Friday morning market activity shows Stryker shares up by 0.43%, trading at $390.56. This implies a total value of $1,463,721 for Becker's 4,980 shares.

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements ...

Citi’s 2025 Unplugged Medtech and Life Sciences Access Day February 27, 2025 12:15 PM ETCompany ParticipantsPreston Wells ...

The product portfolio includes hip and knee replacements ... and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the ...

In addition, we launched ExcelsiusFlex robotic navigation platform and the ACTIFY unicondylar knee system in Q4 ... And we just saw Stryker sell their implant business and retain the ...

Stryker Corporation SYK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks Consensus Estimate of $3.87 by 3.6%. The bottom line also improved 15.9% year ...

Furthermore, the entire knee surgery process is exceedingly arduous. In the case of Total Knee Arthroplasty (TKA), for example, the procedure requires the joint participation of many medical personnel ...